Volume 13; Issue 1

The Pharmacogenomics Journal

Volume 13; Issue 1

1

Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects

Sim, S C, Kacevska, M, Ingelman-Sundberg, M

Journal:

The Pharmacogenomics Journal

Year:

2013

Language:

english

File:

PDF, 629 KB

english, 2013

2

Genomics of ADME gene expression: mapping expression quantitative trait loci relevant for absorption, distribution, metabolism and excretion of drugs in human liver

Schröder, A, Klein, K, Winter, S, Schwab, M, Bonin, M, Zell, A, Zanger, U M

Journal:

The Pharmacogenomics Journal

Year:

2013

Language:

english

File:

PDF, 1.36 MB

english, 2013

3

Serotonin receptor 2A (HTR2A) gene polymorphism predicts treatment response to venlafaxine XR in generalized anxiety disorder

Lohoff, F W, Aquino, T D, Narasimhan, S, Multani, P K, Etemad, B, Rickels, K

Journal:

The Pharmacogenomics Journal

Year:

2013

Language:

english

File:

PDF, 341 KB

english, 2013

4

Characterization of the melanocortin-4-receptor nonsense mutation W16X in vitro and in vivo

Bolze, F, Rink, N, Brumm, H, Kühn, R, Mocek, S, Schwarz, A-E, Kless, C, Biebermann, H, Wurst, W, Rozman, J, Klingenspor, M

Journal:

The Pharmacogenomics Journal

Year:

2013

Language:

english

File:

PDF, 3.43 MB

english, 2013

5

ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease

Onouchi, Y, Suzuki, Y, Suzuki, H, Terai, M, Yasukawa, K, Hamada, H, Suenaga, T, Honda, T, Honda, A, Kobayashi, H, Takeuchi, T, Yoshikawa, N, Sato, J, Shibuta, S, Miyawaki, M, Oishi, K, Yamaga, H, Aoya

Journal:

The Pharmacogenomics Journal

Year:

2013

Language:

english

File:

PDF, 294 KB

english, 2013

6

Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations

Wheeler, H E, Gamazon, E R, Stark, A L, O'Donnell, P H, Gorsic, L K, Huang, R S, Cox, N J, Dolan, M E

Journal:

The Pharmacogenomics Journal

Year:

2013

Language:

english

File:

PDF, 1.68 MB

english, 2013

7

A whole-genome association study of major determinants for allopurinol-related Stevens–Johnson syndrome and toxic epidermal necrolysis in Japanese patients

Tohkin, M, Kaniwa, N, Saito, Y, Sugiyama, E, Kurose, K, Nishikawa, J, Hasegawa, R, Aihara, M, Matsunaga, K, Abe, M, Furuya, H, Takahashi, Y, Ikeda, H, Muramatsu, M, Ueta, M, Sotozono, C, Kinoshita, S,

Journal:

The Pharmacogenomics Journal

Year:

2013

Language:

english

File:

PDF, 764 KB

english, 2013

8

DPP6 as a candidate gene for neuroleptic-induced tardive dyskinesia

Tanaka, S, Syu, A, Ishiguro, H, Inada, T, Horiuchi, Y, Ishikawa, M, Koga, M, Noguchi, E, Ozaki, N, Someya, T, Kakita, A, Takahashi, H, Nawa, H, Arinami, T

Journal:

The Pharmacogenomics Journal

Year:

2013

Language:

english

File:

PDF, 959 KB

english, 2013

9

A genomic approach to predict synergistic combinations for breast cancer treatment

Soldi, R, Cohen, A L, Cheng, L, Sun, Y, Moos, P J, Bild, A H

Journal:

The Pharmacogenomics Journal

Year:

2013

Language:

english

File:

PDF, 2.18 MB

english, 2013

10

Gray matter textural heterogeneity as a potential in-vivo biomarker of fine structural abnormalities in Asperger syndrome

Radulescu, E, Ganeshan, B, Minati, L, Beacher, F D C C, Gray, M A, Chatwin, C, Young, R C D, Harrison, N A, Critchley, H D

Journal:

The Pharmacogenomics Journal

Year:

2013

Language:

english

File:

PDF, 1.47 MB

english, 2013

11

CYP4A11 variant is associated with high-density lipoprotein cholesterol in women

White, C C, Feng, Q, Cupples, L A, Gainer, J V, Dawson, E P, Wilke, R A, Brown, N J

Journal:

The Pharmacogenomics Journal

Year:

2013

Language:

english

File:

PDF, 514 KB

english, 2013